Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Ingenol Mebutate Versus 5% 5-fluorouracil Versus 5% Imiquimod Versus Photodynamic Therapy in Treatment of Actinic Keratosis: a Multi-centre Randomized Efficacy and Cost-effectiveness Study

NCT02281682 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT02281682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02281682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Ingenol Mebutate Versus 5% 5-fluorouracil Versus 5% Imiquimod Versus Photodynamic Therapy in Treatment of Actinic Keratosis: a Multi-centre Randomized Efficacy and Cost-effectiveness Study
Lead sponsor
Maastricht University Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2014
Completion date
December 31, 2018
Enrollment
624 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

keratosis, actinic